Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2012 | 1 |
2013 | 3 |
2014 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Combating immunosuppression in glioma.
Future Oncol. 2008 Jun;4(3):433-42. doi: 10.2217/14796694.4.3.433.
Future Oncol. 2008.
PMID: 18518768
Free PMC article.
Review.
A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model.
Yang S, Archer GE, Flores CE, Mitchell DA, Sampson JH.
Yang S, et al.
Cancer Immunol Immunother. 2013 Nov;62(11):1649-62. doi: 10.1007/s00262-013-1464-0. Epub 2013 Aug 27.
Cancer Immunol Immunother. 2013.
PMID: 23982483
Free PMC article.
Item in Clipboard
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.
Sampson JH, Schmittling RJ, Archer GE, Congdon KL, Nair SK, Reap EA, Desjardins A, Friedman AH, Friedman HS, Herndon JE 2nd, Coan A, McLendon RE, Reardon DA, Vredenburgh JJ, Bigner DD, Mitchell DA.
Sampson JH, et al.
PLoS One. 2012;7(2):e31046. doi: 10.1371/journal.pone.0031046. Epub 2012 Feb 27.
PLoS One. 2012.
PMID: 22383993
Free PMC article.
Clinical Trial.
Item in Clipboard
Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice.
Sanchez-Perez LA, Choi BD, Archer GE, Cui X, Flores C, Johnson LA, Schmittling RJ, Snyder D, Herndon JE 2nd, Bigner DD, Mitchell DA, Sampson JH.
Sanchez-Perez LA, et al.
PLoS One. 2013;8(3):e59082. doi: 10.1371/journal.pone.0059082. Epub 2013 Mar 18.
PLoS One. 2013.
PMID: 23527092
Free PMC article.
Item in Clipboard
Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma.
Choi BD, Suryadevara CM, Gedeon PC, Herndon JE 2nd, Sanchez-Perez L, Bigner DD, Sampson JH.
Choi BD, et al.
J Clin Neurosci. 2014 Jan;21(1):189-90. doi: 10.1016/j.jocn.2013.03.012. Epub 2013 Sep 17.
J Clin Neurosci. 2014.
PMID: 24054399
Free PMC article.
Item in Clipboard
Cite
Cite